Blood Transfusion Market Analysis 2026

Global Blood Transfusion Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Blood Transfusion Market Report Description

We have various report editions of Blood Transfusion Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Blood Transfusion Market Insights Video

Competitive Landscape of the Blood Transfusion

The Blood Transfusion Devices Market is moderately competitive. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with cost-effective pricing. 

• For instance, in May 2020, the Defense Department of the U.S. launched an initiative to collect 8,000 donated units of plasma from COVID-19 patients, in order to aid in the development of a successful treatment. This initiative has resulted in the widespread use of plasmapheresis equipment and disposables in the U.S.

(Source:www.defense.gov/News/News-Stories/article/article/2202507/dod-launches-effort-to-collect-8000-units-of-covid-19-convalescent-plasma/)

Top Companies Market Share in Blood Transfusion Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

North America dominated the market in 2023 and accounted for around 40% of the global revenue.

According to Cognitive Market Research, North America dominated the market in 2023 and accounted for around 40% of the global revenue. The region witnesses a continual demand for blood and blood products, driven by an aging population and various medical procedures. Advanced technologies, automated systems, and sophisticated instruments dominate the market, contributing to efficient blood processing and management.

The Blood Transfusion market in Europe is characterized by Collaboration between healthcare organizations and research institutions, fostering continuous innovation and the implementation of best practices. Increasing awareness regarding the importance of voluntary blood donation and the rising demand for blood components further drive the market’s growth.

The current report Scope analyzes Blood Transfusion Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Blood Transfusion Market Analysis

According to Cognitive Market Research, the global Blood Transfusion market size was estimated at USD 2860.88 Million, out of which North America held the major market of more than 40% of the global revenue with market size of USD 7152.2 Million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030, The region exhibits a well-established network of blood banks and transfusion centers, ensuring prompt and efficient blood supply. Technological advancements in blood screening and processing techniques further enhance the safety and efficacy of transfusions. Additionally, a growing aging population increases the need for blood transfusions in various medical settings. The market also benefits from strong collaborations between healthcare organizations and blood service providers. The dominant segment in North America is Reagents & Kits. This segment encompasses a diverse range of chemical substances, solutions, and test kits designed to detect, analyze, and quantify biological markers or substances in clinical samples. In the context of blood transfusion, reagents and kits are essential components for blood typing, cross-matching, and infectious disease screening.

In conclusion, the North American blood transfusion market is poised for sustained growth, driven by robust healthcare infrastructure, technological advancements, and increasing healthcare needs. Strategic collaborations and ongoing initiatives to overcome regulatory challenges will likely contribute to the market’s continued expansion in the region

Europe Blood Transfusion Market Analysis

According to Cognitive Market Research, the global Blood Transfusion market size was estimated at USD 2145.66 Million, out of which Europe held the major market of more than 30% of the global revenue with market size of USD 7152.2 Million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030, The region exhibits a well-established network of blood donation centers and advanced blood processing facilities, ensuring a stable and safe blood supply. Technological advancements in blood screening and storage techniques contribute to the high standards of transfusion safety. The dominant segment in Europe is Hospitals. The efficient coordination between hospital staff and blood banks is essential to meet patient needs promptly. Technological advancements in transfusion medicine, such as improved blood typing methods and storage solutions, further enhance the capabilities of hospitals in managing blood-related healthcare challenges.

In conclusion, the European blood transfusion market is poised for sustained growth, driven by a well-established infrastructure, technological advancements, and ongoing initiatives to address challenges. The region’s commitment to ensuring a safe and efficient blood supply positions it for continued advancements in transfusion medicine.

Asia Pacific Blood Transfusion Market Analysis

According to Cognitive Market Research, the global Blood Transfusion market size was estimated at USD 1645.01 Million, out of which Asia Pacific held the major market of more than 23% of the global revenue with market size of USD 7152.2 million in 2023 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030, The region witnesses a substantial demand for blood transfusion services due to a high prevalence of diseases, increasing surgical interventions, and a large population. Developing countries in Asia-Pacific face challenges related to blood safety, adequate infrastructure, and regulatory frameworks. The dominant segment in Asia Pacific is Blood Grouping; This segment is integral not only in blood transfusions but also in prenatal care, where knowledge of the mother's and fetus’s blood types is essential to prevent hemolytic disease of the newborn.

In conclusion, the Asia-Pacific blood transfusion market presents opportunities for growth, with ongoing efforts to overcome challenges and improve accessibility to safe blood products. Continued investments, regulatory enhancements, and awareness campaigns are critical for the sustained advancement of blood transfusion services in the region.

South America Blood Transfusion Market Analysis

According to Cognitive Market Research, the global Blood Transfusion market size was estimated at USD 357.61 Million, out of which Latin America held the major market of more than 5% of the global revenue with market size of USD 7152.2 million in 2023 and will grow at a compound annual growth rate (CAGR) of 5.6% from 2023 to 2030, The region has experienced a rising demand for blood and blood products due to various factors such as an increasing prevalence of chronic diseases, a growing aging population, and a rise in surgical procedures. The market is characterized by a surge in government initiatives and awareness campaigns promoting voluntary blood donation, which has positively impacted the supply chain. The dominant segment in Latin America is Instruments; technological advancements in this segment focus on enhancing the efficiency and accuracy of blood testing, ensuring compatibility between donors and recipients, and minimizing the risk of transfusion-related complications. Market players are investing in research and development to introduce innovative instruments that address evolving healthcare needs.

In conclusion, Collaboration between public and private sectors, along with continuous investment in technology and education, will be crucial for sustaining and further expanding the blood transfusion market in the region.

Middle East Blood Transfusion Market Analysis

According to Cognitive Market Research, the global Blood Transfusion market size was estimated at USD 143.04 Million, out of which Middle East and Africa held the major market of more than 2.00% of the global revenue with market size of USD 7152.2 million in 2023 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030, The prevalence of anemia, thalassemia, and other blood disorders, coupled with an increasing number of trauma cases and surgical procedures, contributes to a steady demand for blood transfusion services. Additionally, collaborations with international organizations and partnerships with global healthcare companies have aimed to strengthen the overall blood transfusion ecosystem. The dominant segment in MEA is Reagents & Kits, This segment includes blood grouping reagents, infectious disease screening reagents, and other diagnostic kits vital for ensuring the safety and compatibility of blood transfusions. Technological advancements in reagents and kits focus on enhancing the accuracy, efficiency, and rapidity of blood testing procedures, ultimately improving patient outcomes.

In conclusion, Continued investments in education, technology, and infrastructure, along with strategic collaborations, are essential for overcoming existing barriers and ensuring a robust and sustainable blood transfusion system in the Middle East and Africa.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.